| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | SVP, R&D, CMO | Common Stock | 77,803 | $855,054 | $10.99 | 05 Mar 2026 | Direct |
| Emergent BioSolutions Inc. | SVP, R&D, CMO | Employee Stock Option (Right to buy) | 147,833 | 03 Mar 2026 | Direct | ||
| Emergent BioSolutions Inc. | SVP, R&D, CMO | Employee Stock Options (Right to Buy) | 102,999 | 06 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | 03 Mar 2026 | 2 | $0 | 4 | SVP, R&D, CMO | 05 Mar 2026, 21:21 |
| EBS | Emergent BioSolutions Inc. | 14 Dec 2025 | 1 | -$40,426 | 4 | SVP, R&D, CMO | 16 Dec 2025, 16:12 |
| EBS | Emergent BioSolutions Inc. | 06 Mar 2025 | 2 | $0 | 4 | SVP, R&D, CMO | 10 Mar 2025, 16:17 |
| EBS | Emergent BioSolutions Inc. | 15 Dec 2024 | 2 | $0 | 4 | SVP, R&D, CMO | 17 Dec 2024, 17:44 |
| EBS | Emergent BioSolutions Inc. | 18 Nov 2024 | 0 | $0 | 3 | SVP, R&D, CMO | 21 Nov 2024, 16:02 |